Skip to main content
Premium Trial:

Request an Annual Quote

Credit Where Credit Is Due: Aug 18, 2008

Cameron Neylon has a post at Science in the Open that stems from a conversation he had with Michael Eisen and Sean Eddy at the recent Scifoo meeting. In a discussion about the challenge of academic scientists getting credit, Eisen argued that "people got too much credit for datasets already and that making them more widely citeable would actually devalue the contribution," Neylon writes. His own view is that "if we believe that people who develop tools should be more highly valued then there is little point in giving them ‘credit’ unless that ‘credit’ will be taken seriously in hiring decisions."

Meanwhile, in the second half of a post from Esther Dyson at 23andMe's Spittoon blog, she considers the weight scientists place on being able to contribute data and get recognition for it. "You can measure your contribution to the general welfare not just in citations, but in page views, reuse, whatever," she writes.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.